Cargando…
The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study
OBJECTIVE: The curative treatment approach for diffuse large B-cell lymphoma (DLBCL) is controversial even in the rituximab (R) era. The aim of this study was to examine the FcγRIIIA gene polymorphism distribution of DLBCL patients who had been treated with R-CHOP (cyclophosphamide, doxorubicin, vin...
Autores principales: | Büyükkurt, Nurhilal, Özcan, Mehmet Ali, Ergene, Ülkü, Payzın, Bahriye, Tunalı, Sunay, Demirkan, Fatih, Özsan, Hayri, Pişkin, Özden, Ündar, Bülent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451483/ https://www.ncbi.nlm.nih.gov/pubmed/26316483 http://dx.doi.org/10.4274/tjh.2013.0367 |
Ejemplares similares
-
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
por: Solmaz, Serife, et al.
Publicado: (2018) -
Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation
por: Sevindik, Ömür Gökmen, et al.
Publicado: (2015) -
Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?
por: Solmaz Medeni, Şerife, et al.
Publicado: (2018) -
Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
por: Adıyaman, Süleyman Cem, et al.
Publicado: (2019) -
Chronic HIV-1 Infection Alters the Cellular Distribution of FcγRIIIa and the Functional Consequence of the FcγRIIIa-F158V Variant
por: Phaahla, Ntando G., et al.
Publicado: (2019)